Willow Biosciences Inc (WLLW) - Total Assets

Latest as of March 2025: CA$2.31 Million CAD ≈ $1.67 Million USD

Based on the latest financial reports, Willow Biosciences Inc (WLLW) holds total assets worth CA$2.31 Million CAD (≈ $1.67 Million USD) as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Willow Biosciences Inc - Total Assets Trend (2000–2024)

This chart illustrates how Willow Biosciences Inc's total assets have evolved over time, based on quarterly financial data. Also see WLLW market cap overview for the company's overall valuation and market capitalisation.

Willow Biosciences Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Willow Biosciences Inc's total assets of CA$2.31 Million consist of 26.4% current assets and 73.6% non-current assets. Review Willow Biosciences Inc balance sheet liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CAD)	% of Total Assets
Cash & Equivalents	CA$0.00	13.4%
Accounts Receivable	CA$39.00K	1.6%
Inventory	CA$56.00K	2.3%
Property, Plant & Equipment	CA$0.00	0.0%
Intangible Assets	CA$0.00	0.0%
Goodwill	CA$0.00	0.0%

Asset Composition Trend (2000–2024)

This chart illustrates how Willow Biosciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Willow Biosciences Inc stock quote for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Willow Biosciences Inc's current assets represent 26.4% of total assets in 2024, a decrease from 100.0% in 2000.
Cash Position: Cash and equivalents constituted 13.4% of total assets in 2024, up from 0.1% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
Asset Diversification: The largest asset category is inventory at 2.3% of total assets.

Willow Biosciences Inc Competitors by Total Assets

Key competitors of Willow Biosciences Inc based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Beijing Tongrentang Co Ltd SHG:600085	China	CN¥31.82 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Neuland Laboratories Limited NSE:NEULANDLAB	India	Rs29.30 Billion
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	China	CN¥17.01 Billion

Willow Biosciences Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.01	1.42	9.12
Quick Ratio	1.01	1.29	8.97
Cash Ratio	0.00	0.00	0.00
Working Capital	CA$17.00K	CA$702.00K	CA$12.22 Million

Willow Biosciences Inc - Advanced Valuation Insights

This section examines the relationship between Willow Biosciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	9.89
Latest Market Cap to Assets Ratio	2.07
Asset Growth Rate (YoY)	-62.7%
Total Assets	CA$2.49 Million
Market Capitalization	$5.15 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Willow Biosciences Inc's assets at a significant premium (2.07x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Willow Biosciences Inc's assets decreased by 62.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Willow Biosciences Inc (2000–2024)

The table below shows the annual total assets of Willow Biosciences Inc from 2000 to 2024.

Year	Total Assets	Change
2024-12-31	CA$2.49 Million ≈ $1.80 Million	-62.70%
2023-12-31	CA$6.67 Million ≈ $4.83 Million	-63.23%
2022-12-31	CA$18.15 Million ≈ $13.13 Million	-48.17%
2021-12-31	CA$35.02 Million ≈ $25.33 Million	+60.15%
2020-12-31	CA$21.86 Million ≈ $15.82 Million	-35.47%
2019-12-31	CA$33.88 Million ≈ $24.51 Million	+3403.87%
2018-12-31	CA$967.03K ≈ $699.54K	+33.53%
2017-12-31	CA$724.18K ≈ $523.86K	-57.39%
2016-12-31	CA$1.70 Million ≈ $1.23 Million	-29.64%
2015-12-31	CA$2.42 Million ≈ $1.75 Million	-0.55%
2014-12-31	CA$2.43 Million ≈ $1.76 Million	+1.79%
2013-12-31	CA$2.39 Million ≈ $1.73 Million	+11.65%
2012-12-31	CA$2.14 Million ≈ $1.55 Million	-29.74%
2011-12-31	CA$3.04 Million ≈ $2.20 Million	-18.37%
2010-12-31	CA$3.73 Million ≈ $2.70 Million	-33.03%
2009-12-31	CA$5.56 Million ≈ $4.02 Million	+27.20%
2008-12-31	CA$4.37 Million ≈ $3.16 Million	+42.36%
2007-12-31	CA$3.07 Million ≈ $2.22 Million	+394.02%
2006-12-31	CA$621.91K ≈ $449.88K	+31.68%
2005-12-31	CA$472.29K ≈ $341.65K	+44455.66%
2004-12-31	CA$1.06K ≈ $766.79	-98.90%
2002-12-31	CA$96.40K ≈ $69.74K	-2.90%
2001-12-31	CA$99.28K ≈ $71.81K	-9.61%
2000-12-31	CA$109.83K ≈ $79.45K	--

About Willow Biosciences Inc

TO:WLLW Canada Drug Manufacturers - Specialty & Generic

Market Cap

$18.10 Million

CA$25.02 Million CAD

Market Cap Rank

#28607 Global

#1272 in Canada

Share Price

CA$0.17

Change (1 day)

+0.00%

52-Week Range

CA$0.17 - CA$0.17

All Time High

CA$2.08